Invasive properties of cancer - a treatment target?: In vitro studies in human prostate cancer cell lines
Has parts
Skogseth, Haakon R.; Larsson, Erik; Halgunset, Jostein. Inhibitors of tyrosine kinase inhibit the production of urokinase plasminogen activator in human prostatic cancer cells. APMIS. 113(5): 332-9, 2005.Skogseth, Haakon R.; Larsson, Erik; Halgunset, Jostein. The invasive behavior of prostatic cancer cells is suppressed by inhibitors of tyrosine kinase. APMIS. 114(1): 61-6, 2006.
Skogseth, Haakon R.; Larsson, Erik; Halgunset, Jostein. Urokinase plasminogen activator receptor (uPAR) expression is reduced by tyrosine kinase inhibitors. APMIS. 114(4): 307-13, 2006.
Skogseth, Haakon R.; Follestad, Turid; Larsson, Erik; Halgunset, Jostein. The transcription levels of invasion related genes in prostate cancer cells are modified by inhibitors of tyrosine kinase. APMIS. 114(5): 364-71, 2006.
Skogseth, Haakon R.; Holt, Randi Utne; Larsson, Erik; Halgunset, Jostein. Tyrosine kinase inhibitors alter adhesivity of prostatic cancer cells to extracellular matrix components. APMIS . 114(3): 225-33, 2006.